Contreras HR, Ledezma RA, Vergara J, Cifuentes F, Barra C, Cabello P, Gallegos I, Morales B, Huidobro C, Castellón EA. The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer. Urol Oncol. 2010; 28 (5): 534-40. PMID: 19450993.

Ledezma R, Cifuentes F, Gallegos I, Fullá J, Ossandon E, Castellon EA, Contreras HR. Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer. Asian J Androl. 2011; 13(3):476-80. PMID: 21317913

Mercado A, Fernández MI, Recabal P, Fleck D, Ledezma R, Moya F, Sepúlveda F, Vilches R, Reyes D, Marchant F. Immediate postoperative morbidity in patients with indwelling double-J stent versus overnight-externalized ureteral catheter after tubeless percutaneous nephrolithotomy: a prospective, randomized study. Urolithiasis. 2013; 41(3): 253-6.

Vilches RM, Aliaga A, Reyes D, Sepulveda F, Mercado A, Moya F, Ledezma R, Hidalgo JP, Olmedo T, Marchant F. Comparison between retrograde intrarenal surgery and extracorporeal shock wave lithotripsy in the treatment of lower pole kidney stones up to 15mm. Prospective randomized study. Actas Urol Esp. 2015; 39 (4):236-42.

Ledezma RA, Negron E, Razmaria AA, Dangle P, Eggener SE, Shalhav AL, Zagaja GP. Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes. World J Urol. 2015; 33 (11): 1689-94. PMID: 25701128.

Cohen A, Ledezma R, Mhoon E, Zagaja G. Bloody otorrhea after robotically assisted laparoscopic prostatectomy. Can J Urol. 2015 Jun;22(3):7834-5. PMID: 26068636.

Ledezma RA, Negron E, Paner GP, Rjepaj C, Lascano D, Haseebuddin M, Dangle P, Shalhav AL, Crist H, Raman JD , DeCastro GJ, Harik L, Paroder M, Uzzo RG, Kutikov A, Eggener SE. Clinically Localized Type 1 and 2 Papillary Renal Cell Carcinoma Have Similar Survival Outcomes Following Surgery. World J Urol. 2016; 34 (5): 687-93. PMID: 26407582.